Trump Has Stake In Hydroxychloroquine Drugmaker: Report - 2020-04-07

From UmbraXenu
Jump to: navigation, search
F364.png Trump Has Stake In Hydroxychloroquine Drugmaker: Report April 7, 2020, Ron Dicker, Huffington Post

President Donald Trump reportedly owns a stake in a company that produces hydroxychloroquine, the anti-malaria drug he has repeatedly touted as a coronavirus treatment even though his experts say there's no strong evidence it works.

Trump "has a small personal financial interest" in Sanofi, the French drugmaker that makes Plaquenil, the brand-name version of hydroxychloroquine, The New York Times reported Monday.

In addition, Sanofi's largest shareholders include a mutual fund company run by major Republican donor Ken Fisher, the paper said. Trump's three family trusts, as of last year, each had investments in a mutual fund whose largest holding was Sanofi, according to the Times. Commerce Secretary Wilbur Ross also had ties to the drugmaker, the Times reported.

Wikipedia cite:
{{cite news | first = Ron | last = Dicker | title = Trump Has Stake In Hydroxychloroquine Drugmaker: Report | url = https://www.huffingtonpost.ca/entry/donald-trump-stake-company-hydroxychloroquine_n_5e8c41d7c5b6e1d10a696280?ri18n=true | work = Huffington Post | date = April 7, 2020 | accessdate = April 8, 2020 }}